Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Trappan Bio AB
AB
Active
Org 5591816417
Trappgränd 2
Motion picture projection activities · NACE 5914
Est. 2018
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 2,2M
-10% vs 2024
EBITDA margin
9.4%
+129% vs 2024
Equity ratio
10.4%
Financial strength
Net profit 2025
SEK 31K
-53% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 2,2M
-10%
EBITDA
SEK 206K
+129%
Net profit
SEK 31K
-53%
Total assets
SEK 1,2M
+18%
Equity
SEK 124K
+33%
Employees
1
—
Company information
Legal name
Trappan Bio AB
Org number
5591816417
Legal form
Aktiebolag
NACE code
5914 · Motion picture projection activities
Founded
26 november 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Filmvisning, caféverksamhet
Contact
Address
Trappgränd 2
Email
info@trappanbio.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Motion picture projection activities
Companies in Kungälv
All Sweden companies
Revenue
SEK millions
0M
1M
1M
2M
2M
0M
2021
2M
2022
2M
2023
2M
2024
2M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
2 075
2 275
2 437
2 188
Staff expenses
—
−321
−345
−467
−500
EBITDA
−12
427
−2
90
206
Depreciation & amort.
−0
−2
−7
−9
−37
EBIT
−12
425
−9
81
169
Net financials
—
−2
−0
1
−27
Profit before tax
−12
3
−10
82
42
Tax
−0
—
—
−16
−11
Net profit
−12
3
−10
66
31
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
98
644
613
1 012
1 191
Equity
34
37
27
93
124
Long-term debt
0
7
9
88
240
Short-term debt
64
600
576
830
827
Total debt
64
607
585
919
1 067
Financial ratios
5-year trend
EBITDA margin
9.4%
This company
15.8%
Market median
-41% vs market
2021
2025
Equity ratio
10.4%
This company
38.2%
Market median
-73% vs market
2021
2025
Return on equity
24.9%
This company
18.4%
Market median
+35% vs market
2021
2025
Net profit margin
1.4%
This company
8.1%
Market median
-83% vs market
2021
2025
Asset turnover
1.84×
This company
1.12×
Market median
+64% vs market
2021
2025
Debt / equity
8.61×
This company
0.62×
Market median
-1289% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
LM
Lena Mari Kristiansen
Deputy Board Member
2022
KP
Kent Peter Göran Gustafsson
Board of Directors
2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Pela Kino AB
Company
100%
100%
0001
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Pela Kino AB
Trappan Bio AB
(this company)
Board network connections
Board members of Trappan Bio AB also hold positions in
0
other companies.
Person
Role here
Other companies
Lena Mari Kristiansen
Deputy Board Member
0 companies
Kent Peter Göran Gustafsson
Board of Directors
0 companies